The position is located at a research group established to investigate the molecular and cellular mechanisms underlying human aging and age-related neurodegeneration (especially Alzheimer’s disease/AD), headed by Associate Professor Evandro Fei Fang at the Akershus University Hospital and the University of Oslo, Norway. The research group is The Department of Clinical Molecular Biology is located at Akershus University Hospital where it is a part of the Division of Medicine and Laboratory Sciences, which is the largest division at the Akershus University Hospital Campus, with approximately 40 university employees. The Department has a large and well-equipped molecular biology laboratory that enables advanced translational research. Research themes include: Genome Stability, Cancer Genomics and Cancer Biology, Neurological diseases.  

http://www.med.uio.no/klinmed/english/about/organization/divisions/medicine-laboratory-sciences/clinical-molecular-biology/

The Fang group are focusing on the molecular
mechanisms on how cells clear their damaged and aged mitochondria, a process termed “mitophagy”, as well as the roles of mitophagy in AD. NAD+ is
a fundamental molecule in life and health, and his group is investigating the molecular drivers on how the NAD+-autophagy/mitophagy axis
alleviates ageing and age-predisposed neurodegeneration, especially AD (Nature Neuroscience 2019; Cell Metabolism 2019; Nature Biomedical Engineering 2022; Brain 2026; Nature Ageing 2026). He is fascinated with and actively engaged in moving his laboratory findings to translational applications, as involved in 5 NAD+-based clinical trials as well as co-leading a phase II clinical
trial in investigating effect of a mitophagy inducer urolithin A against Alzheimer´s disease (funded by Alzheimer´s Association), with the overarching goal to establish novel and safe biological approaches to promote longer and healthier human lives. Recent publications of the Fang lab are available at https://evandrofanglab.com/publications/. 

More information of the Fang lab: https://evandrofanglab.com/

Kvalifikasjoner:

Qualification requirements

The prospective candidate is expected to be qualified
1) a master degree (in medicine, public health, biology, neuroscience, or related fields) (mandatory);
2) evidenced good experience in writing scientific papers – at least 2 first authored high profile research papers (mandatory);
3) evidenced competitive skills in AI and AI-based multi-omics data analyses (mandatory);
4) good communication skills (in Norwegian or English); and
5) successful experience in working as a member of a team. 
 

The ideal candidate

The ideal candidate should have a master degree in related field and evidenced experience in publication of high-profile papers as 1st author as well as competitive skills in using AI as well as AI-based multi-omics data analyses.

Vi tilbyr:

We can offer

1) a competitive salary and standard social insurance;
2) a comprehensive training on the knowledge of biology of ageing and the mechanisms of Alzheimer´s disease;
3) a training on how to perform clinical trials;
4) supervision on publication of high profile research and review papers; and
5) support on long-term career development.
 

Submissions

All applicants must apply electronically via webcruiter and the application must include the below documents:

• Application letter (Cover Letter), including a 1-2 page motivation statement and research interests.
  
• CV (summarizing education, positions, academic work, scientific publications and
  other relevant activity)
  
• Copies of educational certificates and grades (in English or Norwegian)
  
• A list of publications and academic work that the applicant wishes to be considered by the evaluation committee.
  
• Names and contact details of 2-3 referees (name, relation to candidate, e-mail and
  telephone number).

Interviews with the best qualified candidates will be arranged.   
 
Candidates are welcome to contact Dr. Fang (e.f.fang@medisin.uio.no) directly through email for discussion before their formal submission.